Literature DB >> 11054815

Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants.

D B Flaherty1, J P Soria, H G Tomasiewicz, J G Wood.   

Abstract

Microtubules (MTs), primarily composed of alpha and beta tubulin polymers, must often work in concert with microtubule-associated proteins (MAPs) in order to modulate their functional demands. In a mature brain neuron, one of the key MAPs that resides primarily in the axonal compartment is the tau protein. Tau, in the adult human brain, is a set of six protein isoforms, whose binding affinity to MTs can be modulated by phosphorylation. In addition to the role that phosphorylation of tau plays in the "normal" physiology of neurons, hyperphosphorylated tau is the primary component of the fibrillary pathology in Alzheimer's disease (AD). Although many protein kinases are known to phosphorylate tau in vitro, the in vivo players contributing to the hyperphosphorylation of tau remain elusive. The experiments in this study attempt to define which protein kinases and protein phosphatases reside in the associated network of microtubules, thereby being strategically positioned to influence the phosphorylation of tau. Microtubule fractions are utilized to determine which of the microtubule-associated kinases most readily impacts the phosphorylation of tau at "AD-like" sites. Results from this study indicate that PKA, CK1, GSK3beta, and cdk5 associate with microtubules. Among the MT-associated kinases, GSK3beta and cdk5 most readily contribute to the ATP-induced "AD-like" phosphorylation of tau. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054815     DOI: 10.1002/1097-4547(20001101)62:3<463::AID-JNR16>3.0.CO;2-7

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  58 in total

1.  CDK-5 regulates the abundance of GLR-1 glutamate receptors in the ventral cord of Caenorhabditis elegans.

Authors:  Peter Juo; Tom Harbaugh; Gian Garriga; Joshua M Kaplan
Journal:  Mol Biol Cell       Date:  2007-08-01       Impact factor: 4.138

Review 2.  Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease.

Authors:  Zhao Zhong Chong; Faqi Li; Kenneth Maiese
Journal:  Brain Res Brain Res Rev       Date:  2005-01-08

Review 3.  Tau as a therapeutic target for Alzheimer's disease.

Authors:  A Boutajangout; E M Sigurdsson; P K Krishnamurthy
Journal:  Curr Alzheimer Res       Date:  2011-09       Impact factor: 3.498

4.  Combinatorial Tau pseudophosphorylation: markedly different regulatory effects on microtubule assembly and dynamic instability than the sum of the individual parts.

Authors:  Erkan Kiris; Donovan Ventimiglia; Mehmet E Sargin; Michelle R Gaylord; Alphan Altinok; Kenneth Rose; B S Manjunath; Mary Ann Jordan; Leslie Wilson; Stuart C Feinstein
Journal:  J Biol Chem       Date:  2011-02-02       Impact factor: 5.157

Review 5.  Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies.

Authors:  Yoshinari Miyata; John Koren; Janine Kiray; Chad A Dickey; Jason E Gestwicki
Journal:  Future Med Chem       Date:  2011-09       Impact factor: 3.808

Review 6.  Cdk5: mediator of neuronal development, death and the response to DNA damage.

Authors:  Jinqiu Zhu; Wenming Li; Zixu Mao
Journal:  Mech Ageing Dev       Date:  2011-05-11       Impact factor: 5.432

7.  Reduced CXCL12/CXCR4 results in impaired learning and is downregulated in a mouse model of Alzheimer disease.

Authors:  A Parachikova; C W Cotman
Journal:  Neurobiol Dis       Date:  2007-07-10       Impact factor: 5.996

8.  Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy.

Authors:  Elizabeth A Grace; Jorge Busciglio
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

9.  Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau.

Authors:  Kim N Green; Joan S Steffan; Hilda Martinez-Coria; Xuemin Sun; Steven S Schreiber; Leslie Michels Thompson; Frank M LaFerla
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

10.  No association of CDK5 genetic variants with Alzheimer's disease risk.

Authors:  José Luis Vázquez-Higuera; Ignacio Mateo; Pascual Sánchez-Juan; Eloy Rodríguez-Rodríguez; Jon Infante; José Berciano; Onofre Combarros
Journal:  BMC Med Genet       Date:  2009-07-17       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.